Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
TOVX
)
3.295
-0.305 (-8.47%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
177,729
Open
4.200
Bid (Size)
3.240 (1)
Ask (Size)
3.460 (1)
Prev. Close
3.600
Today's Range
3.132 - 4.200
52wk Range
0.1066 - 4.200
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Theriva Biologics Receives Rare Pediatric Drug Designation From FDA For Treatment Of Retinoblastoma
Today 8:45 EDT
Theriva Biologics Receives Rare Pediatric Drug Designation From FDA For Treatment Of Retinoblastoma
Via
News Direct
Exposures
Product Safety
Peering Into Theriva Biologics's Recent Short Interest
August 20, 2024
Via
Benzinga
Performance
YTD
+647.17%
+647.17%
1 Month
+1052.90%
+1052.90%
3 Month
+1115.87%
+1115.87%
6 Month
+586.46%
+586.46%
1 Year
+558.87%
+558.87%
More News
Read More
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
August 19, 2024
Via
Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
What's Going On With Theriva Biologics (TOVX) Stock?
August 19, 2024
Via
Benzinga
Preview: Theriva Biologics's Earnings
March 22, 2024
Via
Benzinga
Earnings Outlook For Theriva Biologics
November 10, 2023
Via
Benzinga
Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
August 19, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
August 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
TOVX Stock Earnings: Theriva Biologics Beats EPS for Q2 2024
August 13, 2024
Via
InvestorPlace
Theriva Biologics Advances Its Product Pipeline To Improve Survival Rates For Many Difficult-To-Treat Cancers
August 01, 2024
Via
News Direct
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
June 10, 2024
Via
Benzinga
Theriva Biologics Receives Fast Track Designation From FDA For VCN-01 For Treating Metastatic Pancreatic Cancer
June 07, 2024
Via
News Direct
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 05, 2024
Via
Benzinga
TOVX Stock Earnings: Theriva Biologics Beats EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
April 23, 2024
Via
Benzinga
Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers
April 17, 2024
Via
News Direct
Earnings Scheduled For March 25, 2024
March 25, 2024
Via
Benzinga
How Theriva Biologics Is Using An Adenovirus To Develop A Novel Treatment For Pancreatic Cancer, As Well As Other Cancers With An Unmet Need
March 14, 2024
Via
News Direct
Topics
Death
Exposures
Death
Could This Common Virus Unlock New Cancer Treatments? Theriva Biologics Believes That Adenoviruses Could Be Instrumental In The Next Evolution Of Oncology
March 06, 2024
Via
News Direct
For The First Time The US Is Set To Hit 2 Million New Cancer Cases: Theriva Biologics Presents Novel Solutions To The Deadliest Cancers
February 29, 2024
Via
News Direct
Topics
Death
Exposures
Death
12 Health Care Stocks Moving In Monday's Intraday Session
December 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 18, 2023
Via
Benzinga
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.